生化学 announced a downward revision to its consolidated earnings forecast for the fiscal year ending March 2027 and expects an operating loss of ¥2.05 billion.
生化学 has lowered its consolidated earnings forecast for the fiscal year ending March 2027 and is expected to report an operating loss of ¥2.05 billion.
The body of the report contains no other specific figures.